Diabetes Treatment Report

www.DiabetesTreatmentReport.com

Phase 1

Device-Less Technique in Islet Transplantation

https://clinicaltrials.gov/ct2/show/NCT05073302?type=Intr&cond=Diabetes+Mellitus%2C+Type+1&phase=0124&lupd_s=09%2F27%2F2021&lupd_d=14&sort=nwst

STUDY TITLE:
Device-Less Technique in Islet Transplantation

DESCRIPTION:
Condition:   Type 1 Diabetes
Intervention:   Procedure: Implantation of Nylon catheter (Device-less sentinel unit)
Sponsors:   University of Alberta;   Juvenile Diabetes Research Foundation
Not yet recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT05073302

FIRST POSTED:
Mon, 11 Oct 2021 12:00:00 EDT

LAST UPDATE POSTED:
10/11/21 07:14AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT05073302?type=Intr&cond=Diabetes+Mellitus%2C+Type+1&phase=0124&lupd_s=09%2F27%2F2021&lupd_d=14&sort=nwst

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

https://clinicaltrials.gov/ct2/show/NCT04786262?type=Intr&cond=Diabetes+Mellitus%2C+Type+1&phase=0124&lupd_s=02%2F22%2F2021&lupd_d=14&sort=nwst

STUDY TITLE:
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

DESCRIPTION:
Conditions:   Diabetes Mellitus, Type 1;   Impaired Hypoglycemic Awareness;   Severe Hypoglycemia
Intervention:   Biological: VX-880
Sponsor:   Vertex Pharmaceuticals Incorporated
Not yet recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT04786262

FIRST POSTED:
Mon, 08 Mar 2021 12:00:00 EST

LAST UPDATE POSTED:
03/08/21 06:09AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT04786262?type=Intr&cond=Diabetes+Mellitus%2C+Type+1&phase=0124&lupd_s=02%2F22%2F2021&lupd_d=14&sort=nwst

Islet Transplant in Patients With Type I Diabetes

https://clinicaltrials.gov/ct2/show/NCT03698396?type=Intr

https://clinicaltrials.gov/ct2/show/NCT03698396?type=Intr&cond=Diabetes+Mellitus%2C+Type+1&phase=0124&lupd_s=07%2F16%2F2020&lupd_d=14&sort=nwst

STUDY TITLE:
Islet Transplant in Patients With Type I Diabetes

DESCRIPTION:
Condition:   Diabetes Mellitus, Type 1
Intervention:   Biological: Allogenic Islet Cell Transplantation
Sponsor:   Kenneth Brayman, MD
Recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT03698396

FIRST POSTED:
Tue, 09 Oct 2018 12:00:00 EDT

LAST UPDATE POSTED:
07/30/20 07:16AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03698396?type=Intr&cond=Diabetes+Mellitus%2C+Type+1&phase=0124&lupd_s=07%2F16%2F2020&lupd_d=14&sort=nwst

Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells

https://clinicaltrials.gov/ct2/show/NCT04061746

Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells

Study Type : Interventional
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
Estimated Study Start Date : October 1, 2019
Estimated Primary Completion Date : July 1, 2023
Estimated Study Completion Date : July 1, 2023

A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

https://clinicaltrials.gov/ct2/show/NCT03465878

A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

Study Type : Interventional
Estimated Enrollment : 45 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Children, Adolescents, and Adults With Type 1 Diabetes Mellitus
Actual Study Start Date : March 26, 2018
Estimated Primary Completion Date : September 30, 2019
Estimated Study Completion Date : September 30, 2019

A Safety, Tolerability and Efficacy Study of Sernova’s Cell Pouch™ for Clinical Islet Transplantation

https://clinicaltrials.gov/ct2/show/NCT03513939

A Safety, Tolerability and Efficacy Study of Sernova’s Cell Pouch™ for Clinical Islet Transplantation

Study Type : Interventional
Estimated Enrollment : 7 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Prospective, non-randomized, single arm
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Safety, Tolerability and Efficacy Study of Sernova’s Cell Pouch™ for Clinical Islet Transplantation
Actual Study Start Date : February 7, 2019
Estimated Primary Completion Date : July 2020
Estimated Study Completion Date : February 2022

Back to top